"Drug Evaluation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.
| Descriptor ID |
D004341
|
| MeSH Number(s) |
E05.337.425
|
| Concept/Terms |
Drug Evaluation- Drug Evaluation
- Drug Evaluations
- Evaluation, Drug
- Evaluations, Drug
- Evaluation Studies, Drug
- Drug Evaluation Studies
- Drug Evaluation Study
- Evaluation Study, Drug
- Studies, Drug Evaluation
- Study, Drug Evaluation
|
Below are MeSH descriptors whose meaning is more general than "Drug Evaluation".
Below are MeSH descriptors whose meaning is more specific than "Drug Evaluation".
This graph shows the total number of publications written about "Drug Evaluation" by people in this website by year, and whether "Drug Evaluation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 3 | 3 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 2 | 3 |
| 2008 | 2 | 2 | 4 |
| 2009 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Evaluation" by people in Profiles.
-
Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19. JAMA Netw Open. 2021 11 01; 4(11):e2132540.
-
Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop. Gastroenterology. 2016 09; 151(3):407-11.
-
Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma. Cancer Immunol Res. 2015 Sep; 3(9):986-91.
-
Key concepts of clinical trials: a narrative review. Postgrad Med. 2011 Sep; 123(5):194-204.
-
Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia. 2009 May; 50(5):1141-9.
-
Histone deacetylase inhibitor romidepsin has differential activity in core binding factor acute myeloid leukemia. Clin Cancer Res. 2008 Nov 01; 14(21):7095-101.
-
The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend. 2008 Jul 01; 96(1-2):1-15.
-
Major joint replacement. A model for antithrombotic drug development: from proof-of-concept to clinical use. Int Angiol. 2008 Feb; 27(1):60-7.
-
Beta-blocker therapy in hypertension: a need to pause and reflect. J Am Coll Cardiol. 2008 Jan 29; 51(4):516-7; author reply 517-8.
-
Monitoring late-onset toxicities in phase I trials using predicted risks. Biostatistics. 2008 Jul; 9(3):442-57.